Skip to main content
Cresco Labs Inc. logo

Cresco Labs Inc. — Investor Relations & Filings

Ticker · CRLBF ISIN · CA22587M1068 LEI · 549300NSGBTQRF1IBL30 CSE Manufacturing
Filings indexed 386 across all filing types
Latest filing 2025-10-22 Regulatory Filings
Country CA Canada
Listing CSE CRLBF

About Cresco Labs Inc.

https://www.crescolabs.com/

Cresco Labs Inc. is a vertically integrated, multistate operator in the cannabis industry, specializing in the cultivation, manufacturing, distribution, and retail sale of medical and adult-use cannabis products. The company manages a portfolio of proprietary brands, including Cresco Cannabis, High Supply, and Mindys Edibles, offering various formats such as flowers, concentrates, and edibles. Cresco Labs distributes its products wholesale and through its national dispensary network, primarily branded Sunnyside, across the United States and Germany. The company focuses on professionalizing the cannabis experience, maintaining high-quality production standards, and promoting industry responsibility through advocacy and community initiatives.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2025-10-22 English
Decision Document (Final).pdf
Regulatory Filings Classification · 83% confidence The document is a regulatory receipt from the British Columbia Securities Commission acknowledging the filing of a Short Form Base Shelf Prospectus. It does not present financial results, management discussion, or a meeting notice, nor is it the prospectus itself. It serves as a general regulatory announcement for the issuer’s prospectus filing. Therefore, it falls under the fallback category for miscellaneous regulatory filings (RNS).
2025-10-06 English
Non-issuer's submission to jurisdiction and appointment of agent.pdf
Regulatory Filings Classification · 91% confidence The document is a non-issuer form under National Instrument 41-101, appointing an agent for service of process and submitting to jurisdiction. It is not an earnings, annual, interim, or management report, nor an AGM or proxy statement. It is a regulatory compliance filing required under securities regulation, so it falls under the fallback category Regulatory Filings (RNS).
2025-10-06 English
Non-issuer's submission to jurisdiction and appointment of agent.pdf
Regulatory Filings
2025-10-04 English
Preliminary short form prospectus – English.pdf
Regulatory Filings
2025-10-04 English
Decision Document / Order for Application - French.pdf
Regulatory Filings
2025-10-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.